Clinical Trial Search

Primary: Number of Participants Experiencing Postoperative Nausea and Vomiting in 24h Postoperatively — 14; 14; 25 participants — p=0.021

Primary: Pathologic Complete Response Rate — 8.7; 0.0; 4.3; 0.0 percentage of participants

Primary: Insulin Sensitivity — 3.4; 2.7; 3.2; 3.0 min-1/pmol/mlx10-5 — p=0.55

Primary: Postoperative Blood Loss — 290; 300; 290 ml

Primary: Brief Pain Inventory — 4.5; 5.1 units on a scale — p=.27

Primary: Best Overall Response Rate (BORR) According to PI3K Activation Pathway Status — 49; 21; 70; 1 number of participants

Primary: Assessment of Diabetic Status in the Treatment Period (Type 2 Diabetes Mellitus, Normoglycemia, or Impaired Glucose Tolerance (IGT) — 25; 106; 66 participants

Primary: Number of Healthy Participants Negative for Reaction at 24 Hours After Intradermal Injection With ESAT6-CFP10 — 13; 13; 14; 13 participants

Primary: Change of Daytime Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) Pre-treatment and Post-treatment — -8; -3; -4; -3 mm Hg — p=<0.05

Primary: Positive Syndrome Scale (PANSS) Total Score — -1.05; -1.30 units on a scale

Primary: Percentage of Participants Achieving at Least 4-fold Increase in Titer for Concomitant Trivalent Inactivated Influenza Vaccine (TIV) Antigens 1 Month After Dose 1…

Primary: Peak Activity Index — 0.6; 0.3 change in strides per minute — p=0.586

Primary: Blood Pressure Control — 0.646; 0.543; 0.458; 0.354 proportion of participants — p=0.001

Primary: Increase in Dystrophin Expression in the Muscle Biopsies by Immunofluorescence Analyses of Cross-sections and by Western Blot Analyses of Total Protein Extracts — 1; 1…

Primary: Percentage of Participants Achieving Seroresponse for Diphtheria Toxin, Tetanus Toxin, Pertussis Filamentous Hemagglutinin (FHA), and Poliovirus Type 1, 2, and 3 — 100…